KINAXO Biotechnologies Enters Agreement with Onconova Therapeutics Inc.

15-May-2008

KINAXO Biotechnologies announced a cooperation between Oncovova Therapeutics Inc, Newtown, PA, USA and KINAXO Biotechnologies. Onconova Therapeutics is a clinical stage research and development company focused on development of its novel small molecule products for cancer therapy and radiation protection. KINAXO will apply its Cellular Target Profiling Technology to support Onconova's clinical development of cancer drugs.

KINAXO's Cellular Target Profiling Technology includes identification of a compound's cellular target profile as well as affinity data for targets identified from cell lines. It utilizes proprietary chemical proteomics technologies combined with state-of-the-art mass spectrometry to identify and characterize a drug candidate's native molecular targets in cell lines and tissue samples. The affinity is determined using a free, unmodified compound. This service enables pharmaceutical and biotechnology companies to make more informed decisions on which drug candidates to progress into advanced pre-clinical or clinical development.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic World Mass Spectrometry

Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

3 products
3 brochures
View topic world
Topic World Mass Spectrometry

Topic World Mass Spectrometry

Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

3 products
3 brochures